^
    21d
    CARAML: Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation (clinicaltrials.gov)
    P1, N=10, Active, not recruiting, Great Ormond Street Hospital for Children NHS Foundation Trust | Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2025 --> Jun 2026
    Enrollment closed • Trial primary completion date
    |
    CD33 (CD33 Molecule)
    |
    BE CAR33 T
    over2years
    CARAML: Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation (clinicaltrials.gov)
    P1, N=10, Recruiting, Great Ormond Street Hospital for Children NHS Foundation Trust | Not yet recruiting --> Recruiting
    Enrollment open • CAR T-Cell Therapy
    |
    CD33 (CD33 Molecule)
    |
    BE CAR33 T
    over2years
    CARAML: Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation (clinicaltrials.gov)
    P1, N=10, Not yet recruiting, Great Ormond Street Hospital for Children NHS Foundation Trust
    New P1 trial • CAR T-Cell Therapy
    |
    CD33 (CD33 Molecule)
    |
    BE CAR33 T